TG Therapeutics Inc. Shares Near 52-Week High – Market Mover

Jan 25, 2021

TG Therapeutics Inc. shares closed today at 1.1% below its 52 week high of $24.76, giving the company a market cap of $3B. The stock is currently up 122.1% year-to-date, up 300.0% over the past 12 months, and up 6.7% over the past five years. This week, the Dow Jones Industrial Average rose 1.8%, and the S&P 500 rose 1.3%.

Trading Activity

Trading volume this week was 25.0% lower than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.5.

Technical Indicators

The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
The stock closed at 2.3% higher than its 5-day moving average, 12.2% higher than its 20-day moving average, and 24.1% higher than its 90-day moving average.

Analyst Sentiment

Among analysts who cover the stock, there are currently 6 buy, 0 hold, and 0 sell recommendations
In aggregate, consensus analyst recommendation on the stock is an underweight
The current average analyst price target is $39.50 with a high of $65.00 and a low of $23.00

Market Comparative Performance

The company’s share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis
The company’s share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis
The company share price beats the performance of its peers in the Technology industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis

Per Group Comparative Performance

The company’s price-earnings ratio lags its average peer by -501.0%
The company’s performance over the last 1 year beats its average peer by 2615.6%